secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK:        0001178670
Form:       8-K
Filed at:   2026-03-04T23:59:59+00:00
Accession:  0001628280-26-014728
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Alnylam grants CEO Greenstreet performance-based PSUs tied to $500-$800 stock price by 2029
--------------------------------------------------------------------------------

- Target of 55,373 PSUs ($18.0M face value at $325.07 close on grant date).
- Vesting requires 30-day avg stock price of $500 (50% vest) to $800 (200% vest) by Dec 31, 2029.
- Baseline threshold of $500 exceeds all-time high; award forfeited if price below $500.
- Special award granted alongside annual equity, designed with independent compensation consultant.
- Under Greenstreet, Alnylam achieved ~100% stockholder return, AMVUTTRA approval, and 2025 profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178670/000162828026014728/0001628280-26-014728-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178670/000162828026014728/alny-20260302.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-014728

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer